BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 3511861)

  • 1. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.
    De Silva M; Hazleman BL
    Ann Rheum Dis; 1986 Feb; 45(2):136-8. PubMed ID: 3511861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of polymyalgia rheumatica/giant cell arteritis.
    Kyle V
    Baillieres Clin Rheumatol; 1991 Dec; 5(3):485-91. PubMed ID: 1807823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
    Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
    Kyle V; Hazleman BL
    Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica.
    Reilly PA; Maddison PJ
    Clin Rheumatol; 1987 Jun; 6(2):270-2. PubMed ID: 3621844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
    Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
    Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Azathioprine in the treatment of temporal arteritis and polymyalgia rheumatica].
    Lovschall S
    Ugeskr Laeger; 1977 Oct; 139(44):2618-20. PubMed ID: 145049
    [No Abstract]   [Full Text] [Related]  

  • 8. Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series.
    Diamantopoulos AP; Hetland H; Myklebust G
    Biomed Res Int; 2013; 2013():120638. PubMed ID: 24106691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients.
    Myklebust G; Gran JT
    Scand J Rheumatol; 2001; 30(5):260-7. PubMed ID: 11727839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymyalgia rheumatica].
    Kaiser H
    Verh Dtsch Ges Rheumatol; 1974; 3(0):77-80. PubMed ID: 4839626
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.
    Kyle V; Hazleman BL
    Ann Rheum Dis; 1993 Dec; 52(12):847-50. PubMed ID: 8311533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives.
    Ferraccioli GF; Di Poi E; Damato R
    Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S58-60. PubMed ID: 10948766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
    Durkin SR; Athanasiov PA; Crompton JL
    Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.
    Kyle V; Hazleman BL
    Ann Rheum Dis; 1989 Aug; 48(8):662-6. PubMed ID: 2782976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
    Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].
    Krüger K
    Z Rheumatol; 2007 Oct; 66(6):536-7. PubMed ID: 17849125
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment and diagnosis of polymyalgia rheumatica and temporal arteritis].
    Gran JT
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3387. PubMed ID: 14713975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.